A Research Chair Sample Clauses

A Research Chair is a designation held by a Member with a Full-Time Appointment and can be funded from government, public, private, University or endowed funds. Research Chairs include but are not limited to Canada Research Chairs, Research Chairs sponsored by ORDCF (Ontario Research and Development Challenge Fund) and Research Chairs sponsored by the federal granting councils (NSERC, SSHRC and CIHR). 1.7.1 All Appointments of individuals who will hold a Research Chairs shall be made in accordance with the provisions of this Article unless a Research Chair is being filled by a Member who already has a Probationary or Tenured academic Appointment at The University of Western Ontario, or as explicitly provided for in Clause 1.7.2 of this Article. 1.7.2 Requirements for the advertisement of an Appointment in which the successful appointee will hold a Research Chair may be suspended by the Xxxxxxx at the request of the Appointments Committee through the Xxxx under the following conditions: a) where the Appointment is for one year or less, or b) where the funding is linked or targeted to a particular individual. Such linking of funding to an individual shall require the approval of the Unit’s Appointments Committee. All other appointment procedures must be observed. 1.7.3 The designation of a Member as a Research Chair in a Unit shall not increase the Teaching Workload of other Full-Time Members in the Unit. 1.7.4 The letter designating an individual as a Research Chair shall specify the duties of the position, the stipend and any other compensation or perquisites that accompany the designation, and the resources and support that the Employer agrees to provide for the Member to fulfil his or her Academic Responsibilities as a Research Chair.
Sample 1Sample 2Sample 3See All (9)
AutoNDA by SimpleDocs
A Research Chair is an academic Appointment that is funded from government, public, private or endowed funds. A Research Chair may be an Externally- Funded Appointment or an Open Appointment, but is not limited to these categories. Research Chairs include but are not limited to Canada Research Chairs, Research Chairs sponsored by ORDCF (Ontario Research and Development Challenge Fund) and Research Chairs sponsored by the federal granting councils (NSERC, SSHRC and CIHR). 1.7.1 All Appointments of Research Chairs shall be made in accordance with the provisions of this Article unless a Research Chair is being filled by a Member who already has a Probationary or Tenured academic Appointment at The University of Western Ontario, or as explicitly provided for in Clause 1.7.2 of this Article. 1.7.2 Requirements for the advertisement of a Research Chair Appointment where the Appointment is for one year or less, or where the funding is linked to a particular individual, may be suspended by the Xxxxxxx at the request of the Appointments Committee through the Xxxx. All other appointment procedures must be observed. 1.7.3 The Appointment of a Research Chair in a Unit shall not increase the Teaching Workload of other Full-Time Members in the Unit. 1.7.4 The Letter of Appointment for a Research Chair shall specify the duties of the position, the stipend and any other compensation or perquisites that accompany the Appointment, and the resources and support that the Employer agrees to provide for the Member to fulfil his or her Academic Responsibilities as a Research Chair. In the case of a current Member who is to be appointed to a Research Chair, this may take the form of an amendment to the Member's current Letter of Appointment.
Sample 1Sample 2Sample 3See All (5)
A Research Chair is a designation held by a Member with a Full-Time Appointment and can be funded from government, public, private, University or endowed funds. Research Chairs include but are not limited to Canada Research Chairs, Research Chairs sponsored by ORDCF (Ontario Research and Development Challenge Fund) and Research Chairs sponsored by the federal granting councils (NSERC, SSHRC and CIHR). 1.10.1 All Appointments of individuals who will hold a Research Chairs shall be made in accordance with the provisions of this Article unless a Research Chair is being filled by a Member who already has a Probationary or Tenured academic Appointment at The University of Western Ontario, or as explicitly provided for in Clause 1.10.2 of this Article.
Sample 1Sample 2Sample 3
A Research Chair is a designation held by a Member with a Full-Time Appointment and can be funded from government, public, private, University or endowed funds. Research Chairs include but are not limited to Canada Research Chairs, Research Chairs sponsored by ORDCF (Ontario Research and Development Challenge Fund) and Research Chairs sponsored by the federal granting councils (NSERC, SSHRC and CIHR).
Sample 1

Related to A Research Chair

  • Technology Research Analyst Job# 1810 General Characteristics

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Research Collaboration 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 Within [***] ([***]) days after completion of the [***], Aarvik shall deliver to ArriVent a full report on all key results and findings of the Collaboration Program, and such other data, results and information as ArriVent may deem necessary for it to determine whether or not to exercise the Option (the “Full Report”).

  • Joint Research Committee The Parties hereby establish a committee to facilitate the Research Program as follows:

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Research Term The term “

  • Research Support (a) Having regard to the resources reasonably available for such purposes, the Operator will cooperate with AHS to provide such participation by its Staff as may be reasonable in relation to the carrying out of research within the Province. (b) The Operator agrees to promptly notify AHS in the event that it undertakes or agrees to participate in any form of clinical trial, research project, instrument use, or similar activity which in any way relates to the Services provided under this Agreement. The Operator shall, upon request, provide AHS with written evidence of Client disclosure and consent to research.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!